Korean J Intern Med.
2018 Mar;33(2):435-437. 10.3904/kjim.2015.252.
New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients
- Affiliations
-
- 1Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea.
- 2Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea. sksohn@knu.ac.kr
- KMID: 2411556
- DOI: http://doi.org/10.3904/kjim.2015.252
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Delayed treatment-free response after romiplostim discontinuation in pediatric chronic immune thrombocytopenia
- Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia
- Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
- Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
- Application of vincristine-loaded platelet therapy in three dogs with refractory immune-mediated thrombocytopenia
